Guide · Titer testing

Titer test questions — the confusing parts explained.

Reviewed August 2026 · Based on ACIP Immunization of Health-Care Personnel (MMWR RR-7)¹, the CDC Pink Book², and ACIP General Best Practice Guidelines³. Educational reference, not medical advice.

Titer testing is the least intuitive part of the vaccine documentation process — a "negative" titer doesn't always mean unprotected, "equivocal" is a distinct third result category, and there are different kinds of titers that measure different things. Here are the questions that come up most often, plainly answered.

"Quantitative vs qualitative — which does my school need?"

The two lab report formats:

• Quantitative titer — a numeric value with a reference range. Example: Anti-HBs: 34 mIU/mL (Reference: ≥10 mIU/mL indicates immunity). The specific number lets a reviewer verify against a threshold.
• Qualitative titer — a categorical result only: positive, negative, or equivocal. No number.

Almost every school, employer, and USCIS civil surgeon requires quantitative results. Reasons:

1. Hepatitis B has a specific threshold (≥10 mIU/mL for immunity). Without a number, you can't verify against it.
2. Some reviewers want to see borderline vs. clear-positive numbers to make their own judgment.
3. Qualitative-only reports can hide borderline values that would be flagged on the quantitative version.

When ordering titers, specifically ask for quantitative and confirm the lab report will include the numeric value with reference ranges. If you're using a direct-to-consumer service, check their sample reports before ordering — services like SchoolTiters and LabReqs default to quantitative for the standard immunity panels, but confirm before ordering. Compare providers at Laboratories.org.

"My titer came back 'equivocal.' Is that a pass?"

No — treat it as negative. The CDC's guidance for MMR is explicit¹:

"Measles immunoglobulin (IgG) in the serum; equivocal results should be considered negative."

Same language for mumps and rubella IgG. Most schools and occupational health offices apply the same rule to varicella IgG and hepatitis B anti-HBs — an equivocal reading is not documentation of immunity.

Practical options when this happens:

1. Repeat the titer. Sometimes an equivocal reading is a lab artifact. A repeat on a different sample can come back clearly positive.
2. Get a booster dose. One additional vaccine dose usually clears equivocal-territory antibody levels into clearly positive range. Retiter 4+ weeks later.
3. Accept it as needing revaccination. Some occupational health offices skip the retiter step and just administer the booster series — depends on institutional policy.

"My titer is negative but I know I got vaccinated. Did the vaccine fail?"

Usually not. Two different reasons this happens, with different implications:

1. The assay isn't sensitive enough (MMR, varicella)

Commercial titer assays are calibrated to detect disease-induced immunity (the higher antibody levels from natural infection). Vaccine-induced immunity is often lower — enough to protect you, but not always enough to trip the assay. The CDC explicitly acknowledges this¹:

"Commercial assays can be used to assess disease-induced immunity, but they often lack sensitivity to detect vaccine-induced immunity (i.e., they might yield false-negative results)."

What to do: standard practice is a single booster dose. Some programs re-titer after the booster to document response; some just move on. This isn't evidence your vaccine failed — it's evidence the commercial assay isn't sensitive enough.

2. Antibody waning (Hep B)

Hep B antibody levels naturally decline over time even in people who responded perfectly to the vaccine series. The CDC Pink Book²:

"Vaccine-induced antibody levels decline with time. However, immune memory remains intact for more than 30 years following immunization, and both adults and children with declining antibody levels are still protected against significant HBV infection."

What to do: for healthcare workers, occupational health typically administers one booster dose and re-titers 1-2 months later. A positive titer at that point documents immunity and closes the workup. A still-negative titer triggers a repeat series.

3. Genuine non-response (rare)

About 5-10% of adults don't respond to the standard Hep B series with a protective antibody response, more common in older adults, smokers, and those with diabetes or chronic liver disease. Genuine non-responders typically need a repeat 3-dose series and, if still negative, are considered vaccine non-responders and rely on post-exposure prophylaxis if exposed to Hep B.

The way to distinguish is time. Test 1-2 months after the final vaccine dose using the correct protocol — see the titer timing guide. A negative result then is genuinely negative. A negative result years later is usually just waning antibody, not vaccine failure.

"Should I get a titer first or just get the booster?"

Depends on your situation:

• Get a titer first if: you might already be immune from prior vaccination or infection, and the vaccine isn't due anyway. Common for adults entering nursing school or college who had childhood MMR/varicella but lost records. Titers save you from unnecessary shots and are often required by the school regardless.
• Get the booster first if: the vaccine is due anyway (Tdap every 10 years, annual flu, current-season COVID), or if the titer would cost more than the vaccine itself. Also skip the titer if the school specifically asks for shot records only.
• Both are required if: you're entering a clinical program (nursing, medical, dental). Most of these require both the documented series and a confirmatory titer.

See our deeper guide on titer vs. booster for the specific cost and timing math.

"Do titers work for all vaccines?"

No — this is a common misconception. Titers are useful for four vaccines:

• MMR (measles, mumps, rubella IgG) — works reliably for disease-induced immunity; can miss vaccine-induced immunity per the CDC caveat.
• Varicella (VZV IgG) — same caveat as MMR.
• Hepatitis A (Hep A IgG) — reliable.
• Hepatitis B (anti-HBs surface antibody) — reliable, but tightly tied to timing (1-2 months post-final dose).

Titers don't reliably work for:

• Tdap — no clinically useful pertussis antibody test. Documented vaccine within 10 years is the standard.
• Flu — annual re-immunization is faster than trying to titer for each strain.
• HPV — no clinically useful titer.
• Meningococcal — no routine titer test in commercial use.
• Pneumococcal — antibody testing exists but isn't used to substitute for vaccination.
• Polio — three distinct serotypes (types 1, 2, and 3). USCIS requires immunity to all three, but wild poliovirus type 2 was declared eradicated by the World Health Organization in 2015 and commercial U.S. labs stopped running type 2 antibody testing after that. Every commercial polio titer we're aware of tests only types 1 and 3 — which means the report is incomplete for USCIS purposes and gets rejected. There is no working titer route for polio right now.

"IgG vs IgM — which one is the right titer?"

IgG is what you want for immunity documentation. It's the "long-term memory" antibody that persists after infection or vaccination.

IgM is the "acute infection" antibody — elevated during current or very recent infection, drops off within weeks. If a school or employer asks for a "measles titer," they mean measles IgG. Ordering IgM by mistake is one of the top reasons people get their titer results rejected — the lab did what was ordered, but the report shows an IgM value that's irrelevant to immunity documentation.

When ordering titers, specifically say IgG. For Hep B specifically, the relevant test is anti-HBs (hepatitis B surface antibody), not IgG or IgM.

"Are titers expensive?"

Wide range depending on where you order:

• Through primary care with insurance — usually $0 to $50 out of pocket. Ordered as part of a preventive visit or an occupational medicine visit.
• Pharmacy or independent lab-draw clinic self-pay — $50-$150 per titer, $200-$400 for the full immunity panel.
• Direct-to-consumer services — comparable to self-pay pharmacy, sometimes cheaper. SchoolTiters for school-focused panels, LabReqs for the broader clinical panel. Compare pricing at Laboratories.org.
• Through occupational health at a hospital — usually free if you're a new hire; bundled into onboarding.

The full standard immunity panel (MMR + varicella + Hep A + Hep B) usually runs $150-$300 total self-pay, or $50-$100 with insurance.

Sources

1. CDC — Immunization of Health-Care Personnel: Recommendations of ACIP (MMWR RR-7). Source for the "equivocal results should be considered negative" and "commercial assays lack sensitivity for vaccine-induced immunity" language.
2. CDC Pink Book — Hepatitis B. Source for the Hep B ≥10 mIU/mL threshold, antibody waning language, and the 30-year immune memory reference.
3. CDC — ACIP General Best Practice Guidelines: Timing and Spacing. Source for the "commercial serologic testing might not always be sufficiently sensitive" caveat.